Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · IEX Real-Time Price · USD

8.29

-0.32 (-3.72%)

At close: Apr 18, 2024, 4:00 PM

8.28

-0.01 (-0.12%)

After-hours: Apr 18, 2024, 7:23 PM EDT

Outlook Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-58.98	-66.05	-53.16	-48.87	-36.04	-48.02	-40.03	-63.14	-53	-20.66
Depreciation & Amortization	0.04	0.2	0.26	0.55	3.36	3.05	2.69	2.39	1.82	0.88
Share-Based Compensation	5.55	7.71	4.89	2.81	1.31	1.99	8.57	12.45	11.18	3.96
Other Operating Activities	10.42	1.46	-6.24	0.09	-2.44	-7.99	12.08	-7.03	6.91	1.88
Operating Cash Flow	-42.97	-56.67	-54.25	-31.79	-32.29	-33.04	-15.51	-45.48	-27.48	-7.02
Capital Expenditures	0	0	0	0	-0.44	-2.78	-0.29	-1.1	-8.8	-2.37
Acquisitions	0	0	0	-0.9	0	0	0	0	0	0
Investing Cash Flow	0	0	0	-0.9	-0.44	-2.78	-0.29	-1.1	-8.8	-2.37
Share Issuance / Repurchase	30.02	62.51	49.9	36.57	45.97	14.7	1.86	57.49	41.25	11.04
Debt Issued / Paid	18.94	-2.92	6.3	0.64	-6.94	-2.08	11.29	-13.34	1.58	-1.67
Other Financing Activities	-	-	-	-	-	21.74	3.48	-4.29	0.17	2.1
Financing Cash Flow	48.97	59.59	56.19	37.21	39.03	34.35	16.63	39.86	43	11.47
Net Cash Flow	6	2.92	1.94	4.52	6.3	-1.47	0.83	-6.72	6.72	2.09
Free Cash Flow	-42.97	-56.67	-54.25	-31.79	-32.73	-35.82	-15.8	-46.58	-36.28	-9.39
Free Cash Flow Margin	-	-	-	-	-401.75%	-1160.16%	-414.46%	-1563.34%	-695.13%	-103.72%
Free Cash Flow Per Share	-3.44	-5.34	-7.11	-8.76	-35.98	-145.25	-105.22	-432.98	-595.15	-176.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).